Potential advantages of novel antithrombotic agents administered conjunctively during coronary fibrinolysis

Dana R. Abendschein

doi:10.1097/00019501-199607000-00006

Potential advantages of novel antithrombotic agents administered conjunctively during coronary fibrinolysis

Dana R. Abendschein

Division of Cardiology

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	522-527
Number of pages	6
Journal	Coronary Artery Disease
Volume	7
Issue number	7
DOIs	https://doi.org/10.1097/00019501-199607000-00006
State	Published - 1996

Keywords

anticoagulants
coagulation factors
thrombolysis

Access to Document

10.1097/00019501-199607000-00006

Cite this

@article{d40537318e1747daba4f24b012dadd66,

title = "Potential advantages of novel antithrombotic agents administered conjunctively during coronary fibrinolysis",

keywords = "anticoagulants, coagulation factors, thrombolysis",

author = "Abendschein, \{Dana R.\}",

year = "1996",

doi = "10.1097/00019501-199607000-00006",

language = "English",

volume = "7",

pages = "522--527",

journal = "Coronary Artery Disease",

issn = "0954-6928",

number = "7",

}

TY - JOUR

T1 - Potential advantages of novel antithrombotic agents administered conjunctively during coronary fibrinolysis

AU - Abendschein, Dana R.

PY - 1996

Y1 - 1996

KW - anticoagulants

KW - coagulation factors

KW - thrombolysis

UR - https://www.scopus.com/pages/publications/0029910498

U2 - 10.1097/00019501-199607000-00006

DO - 10.1097/00019501-199607000-00006

M3 - Review article

C2 - 8913670

AN - SCOPUS:0029910498

SN - 0954-6928

VL - 7

SP - 522

EP - 527

JO - Coronary Artery Disease

JF - Coronary Artery Disease

IS - 7

ER -

Potential advantages of novel antithrombotic agents administered conjunctively during coronary fibrinolysis

Keywords

Access to Document

Other files and links

Cite this